Telemedicine is increasingly used for disease monitoring and management of chronic medical and mental disorders, but also has screening and diagnostic applications such as teleradiology and teledermatology. Indeed, "therapy at a distance" will complement office-based care in the 21st century. Another screening application is teleophthalmology, in which digital photography with telemedicine links has proven cost-effective for retinal disorders, including diabetic retinopathy and retinopathy of prematurity. EXPOSURES Clinical medical records were reviewed for a 2-year period after patients were referred from teleretinal screening. The following information was collected for analysis: patient demographics, referral and confirmatory diagnoses, ophthalmology clinic visits, diagnostic procedures, surgical procedures, medications, and spectacle prescriptions.
Telemedicine is increasingly used for disease monitoring and management of chronic medical and mental disorders, but also has screening and diagnostic applications such as teleradiology and teledermatology. Indeed, "therapy at a distance" will complement office-based care in the 21st century. Another screening application is teleophthalmology, in which digital photography with telemedicine links has proven cost-effective for retinal disorders, including diabetic retinopathy and retinopathy of prematurity. 1, 2 In a recent study in JAMA Ophthalmology, Chasan et al 3 complemented prior cost-effectiveness analyses of teleretinal screening programs by examining both the accuracy of diabetic teleretinal screening as well as the subsequent eye care use and resources required in such a program. Regarding accuracy, screening tests that have good sensitivity and specificity are likely to be more cost-effective. Regarding resource use, implementation of screening generates more referrals, testing, and procedures. The cost-effectiveness of any screening program is therefore contingent on reasonable test accuracy coupled with a sufficient supply of resources to meet the increased demand. From The JAMA Network tion was masked to the retinal photograph, which could bias the clinician toward greater agreement and sensitivity. Of the 465 patients referred, 260 patients (56%) made and kept an appointment at the VA eye clinic (another 66 received ophthalmic careoutsidetheVA).UsingMedicarecostdataestimates,themeancost incurred during a 2-year period per patient seen in the eye clinic was approximately $1000. Costs may have been underestimated because medications and spectacles were not included in cost estimates. However, this is not a substantial limitation because it is a reflection of who is actually responsible for certain health care costs. Some eye medications are considered over-the-counter and, like spectacles, may not be coveredbyinsurance.Accordingly,thepatientbearstheadditionalcosts. Also,screeningcosts(cameras,computers,personneldoingtheimaging and reading) were not included in the cost analysis.
The yield of screening may have been overestimated because only 43.6% had a visually significant condition detected for the first time. However, sometimes "the second time is the charm," not only for eye disorders but for other conditions as well, such as risk factors (hypertension, hyperlipidemia) or behaviors warranting lifestyle changes (weight loss, smoking cessation, exercise). Patients may need to hear something more than once before taking a screening result or health care recommendation seriously and to move through the stages of changefromprecontemplationtoaction.Ofthepatientsreferred,there was a 30% nonadherence rate with making and keeping an appointment in either the VA or a non-VA eye clinic. Not surprisingly, patients with historical high no-show rates for medical appointments were less likely to keep an appointment. Because neither age nor driving distance was associated with no-show rates, identifying other potential barriers (patient preferences for treatment, inadequate education about risks, less severe symptoms) is important.
Another recent study in JAMA Ophthalmology provided promising results for telemedicine diagnosis of cytomegalovirus retinitis, a disease common in resource-poor countries with a high burden of human immunodeficiency virus and limited access to highly active antiretroviral therapy. 4 Conducting the study in Thailand, Yen et al 4 found good agreement between nonexpert and expert graders evaluating 182 fundus photographs: the mean sensitivity and specificity values of nonexpertdiagnosisusingexpertconsensusasthereferencestandardwere 93.2%and88.4%,respectively.Meanintraraterreliabilityalsowashigh (mean κ, 0.83). Training consisted simply of a 2-hour workshop, and there were some raters with lower accuracy. The authors argued for more intensive training and periodic evaluations if nonexperts are to be used in clinical practice. A 2-hour training session of nonexpert graders produced similar accuracy for telemedical diagnosis of retinopathy of prematurity. 5 In contrast, a telemedicine program for diabetic retinopathyintheUnitedStateshadamoreintense3-daytrainingprogram after which imagers served a probationary period with senior imager supervision and ongoing quality improvement and assurance. 6 The optimal amount of training likely depends on current or previous health care experience of the trainees, whether screening is focused on 1 type or multiple types of eye disease, and the degree of posttraining supervision and attention to quality improvement. A review of 21 articles on the economic evidence for diabetic retinopathy screening concluded that systematic screening is costeffective and that telemedicine retinal screening has the potential to deliver cost-effective, accessible screening to rural and hard-toreach populations. 1 However, the authors found that variation in adherence rates, frequency of screening (annual vs 2-to 3-year intervals), age at onset of diabetes, glycemic control, and screening sensitivities influence cost-effectiveness. The cost per qualityadjusted life-year (QALY) of teleretinal screening for both diabetic retinopathy and retinopathy of prematurity falls well below the standard benchmark of $50 000 per QALY. 1, 2 There are several implications of this emerging evidence supporting telemedicine for eye disorders. First, telemedicine in general is often promoted as a means of increasing access to care for individuals living in rural, remote, or resource-poor regions. However, it also may be cost-effectiveinurbanareasbyidentifyingtheindividualswhomaybenefit most from specialty referral as well as by reducing time and travel costs by screening at community clinics closer to where individuals reside. Second, telemedicine screening may be more feasible, at least for now, in larger integrated health care systems like the VA, health maintenanceorganizations,oraccountablecareorganizations.Arecentstudy from the VA found that telemedicine screening for diabetic retinopathydidnotbecomecost-effectiveuntilthepatientpoolexceeded3500. 7 However,iftheAffordableCareActfulfillsitspromisebyprovidinghealth coverage for a greater proportion of the US population, telemedicine coverage may also expand. Third, other factors may identify subgroups in which telemedicine screening is more or less cost-effective. For example, the same VA study found that teleretinal screening was actually cost-saving in patients younger than 50 years, cost-effective for those aged50to80years,andnolongercost-effectiveafterapatientexceeds the age of 80 years. 7 Fourth, as telemedicine extends to many conditions,lessonslearnedfromonediseasemaygeneralizetoothers.Asthe pressuresincreaseforhealthcaretobecomemorepatient-centeredand cost-effective,telemedicineisonestrategyforfosteringbothprinciples.
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